银屑病是影响皮肤和关节的一种常见疾病。皮肤银屑病往往周而复始,持续一生,且没有明显病因,因此会让患者痛苦不已。某些银屑病患者的其他家属可能受同样问题困扰,但并非总是如此。银屑病患者会产生更多皮肤细胞,从而在皮肤上层累积并在皮肤上形成片状斑块或严重的头皮屑。该病的病因尚不清楚,被认为涉及到基因和免疫系统,而我们目前采用的治疗仅可控制银屑病,但无法治愈。本研究在英国阿伯丁开展,旨在探究免疫系统的两类细胞;一种可能会诱发或导致银屑病的发生,而另一种有抵抗银屑病和镇静皮肤的能力。我们通过采集血液和皮肤样本测试了我们常用于治疗银屑病的某些注射、乳膏和光线对有关细胞的作用。我们发现,皮肤在六周后好转。光线使得“好”细胞的数量升高,而注射导致“坏”细胞的数量减少并且对“好”细胞没有影响。乳膏会增加“好”细胞并减少“坏”细胞。我们在血液和皮肤中都注意到这些变化,这意味着乳膏和光线可能对血液循环中的细胞产生作用,因此可在未来用于发明更安全的新疗法
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by A. D. Ormerod
Regulatory T cells as a therapeutic target in psoriasis
Psoriasis is a common condition that affects the skin and joints. Skin psoriasis tends to wax and wane throughout life without obvious reasons, and thus causes considerable distress. Someone with psoriasis may have other family members with the same problem but this is not usually the case. In psoriasis, more skin cells are made leading to build‐up on the top layer and formation of flaky patches on the skin or severe dandruff of the scalp.
Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis
Fig S1. Diagrams showing first the selection of the lymphocyte population, and then identification of the pure CD4+ proportion of T cells gated from the isotype control. Fig S2. Diagrams to show the steps involved in subgating of regulatory T cells, firstly on CD4+, then CD25+ cells, to be identified as CD4+ CD25+ FoxP3+ CD127lo. Fig S3. Diagrams to show the steps involved in subgating of T helper 17 cells, firstly on CD4+, then CCR4+ cells, to be identified as CD4+ CCR4+ CCR6+ IL‐23R+. Fig S4.
Generating new evidence, improving clinical practice and developing research capacity: the benefits of recruiting to the U.K. Dermatology Clinical Trials Network's STOP GAP and BLISTER trials - Batchelor - 2017 - British Journal of Dermatology - Wiley Onl
Clinical trials may benefit clinical practice in three ways: firstly, clinicians may change their practice according to the new trial evidence; secondly, clinical processes can improve when working on a trial; and thirdly, research capacity is increased. We held a meeting to present and discuss the results of two large multicentre randomized controlled trials delivered through the U.K. Dermatology Clinical Trials Network.
Five-year efficacy of biologics for psoriasis in the real world of daily practice
Previous article in issue: Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa Previous article in issue: Evidence for a biofilm-based treatment strategy in the management of chronic hidradenitis suppurativa Next article in issue: Cutaneous lymphomas in childhood and adolescence: much needed new data Next article in issue: Cutaneous lymphomas in childhood and adolescence: much needed new data
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with A. D.
Contact A. D., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack